Literature DB >> 6699653

Glutathione peroxidase and reductase, glucose-6-phosphate dehydrogenase and catalase activities in multiple sclerosis.

G E Jensen, J Clausen.   

Abstract

Our previous studies have demonstrated a decreased glutathione feroxidase (GSH-Px) activity of erythrocytes and leucocytes from multiple sclerosis (MS) patients. In the present communication these activities were compared with the activities of associated enzymes (glutathione reductase (GSSG-RD), glucose-6-phosphate dehydrogenase (G-6-PD) and catalase). All enzymic activities were compared between MS patients, other neurologic patients (ON patients) and normal control individuals. Compared to data of ON patients and normal controls, in MS the ratio of GSHPx/GSSGRD in lympho- and granulocytes was significantly decreased (2 alpha less than or equal to 0.05) by 35% and 51%, respectively. The significant correlation between GSSG-RD and the GSH-Px activity (2 alpha less than or equal to 0.05, r = 0.501) found in control lymphocytes was not present in MS lymphocytes. However, the lymphocyte GSH-Px activities of controls as well as of MS correlated with the corresponding serum selenium levels (2 alpha less than or equal to 0.05, r = 0.594 and 2 alpha less than or equal to 0.01, r = 0.967, respectively). The G-6-PD activity was insignificantly increased by 41% in MS lymphocytes compared to normal control. Catalase activity was unchanged in lymphocytes but decreased 50% in MS granulocytes compared to normal control. No significant differences were found between MS and the ON group. The catalase activity of MS erythrocytes was increased by 63% (2 alpha less than or equal to 0.05) in comparison with both the normal control and ON data.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699653     DOI: 10.1016/0022-510x(84)90107-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis.

Authors:  S J van Rensburg; M J Kotze; D Hon; P Haug; J Kuyler; M Hendricks; J Botha; F C V Potocnik; T Matsha; R T Erasmus
Journal:  Metab Brain Dis       Date:  2006-05-26       Impact factor: 3.584

2.  High dose antioxidant supplementation to MS patients. Effects on glutathione peroxidase, clinical safety, and absorption of selenium.

Authors:  J Mai; P S Sørensen; J C Hansen
Journal:  Biol Trace Elem Res       Date:  1990-02       Impact factor: 3.738

3.  Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients.

Authors:  M I Hunter; B C Nlemadim; D L Davidson
Journal:  Neurochem Res       Date:  1985-12       Impact factor: 3.996

4.  Lymphocyte glutathione peroxidase activity during exacerbations in multiple sclerosis.

Authors:  P S Sørensen; J C Hansen; J Mai; L R Nielsen; T Sørensen
Journal:  Biol Trace Elem Res       Date:  1992 Apr-Jun       Impact factor: 3.738

5.  Vitamin B12 and estradiol benzoate improve memory retrieval through activation of the hippocampal AKT, BDNF, and CREB proteins in a rat model of multiple sclerosis.

Authors:  Narjes Taherian; Gholamhassan Vaezi; Ali Neamati; Leila Etemad; Vida Hojjati; Mahmoud Gorji-Valokola
Journal:  Iran J Basic Med Sci       Date:  2021-02       Impact factor: 2.699

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.